Chemosensitization of aflatoxigenic fungi to antimycin A and strobilurin using salicylaldehyde, a volatile natural compound targeting cellular antioxidation system.
Various species of fungi in the genus Aspergillus are the most common causative agents of invasive aspergillosis and/or producers of hepato-carcinogenic mycotoxins. Salicylaldehyde (SA), a volatile natural compound, exhibited potent antifungal and anti-mycotoxigenic activities to A. flavus and A. parasiticus. By exposure to the volatilized SA, the growth of A. parasiticus was inhibited up to 10-75% at 9.5 mM ≤ SA ≤ 16.0 mM, while complete growth inhibition was achieved at 19.0 mM ≤ SA. Similar trends were also observed with A. flavus. The aflatoxin production, i.e., aflatoxin B(1) and B(2) (AFB(1), AFB(2)) for A. flavus and AFB(1), AFB(2), AFG(1), and AFG(2) for A. parasiticus, in the SA-treated (9.5 mM) fungi was reduced by ~13-45% compared with the untreated control. Using gene deletion mutants of the model yeast Saccharomyces cerevisiae, we identified the fungal antioxidation system as the molecular target of SA, where sod1Δ [cytosolic superoxide dismutase (SOD)], sod2Δ (mitochondrial SOD), and glr1Δ (glutathione reductase) mutants showed increased sensitivity to this compound. Also sensitive was the gene deletion mutant, vph2Δ, for the vacuolar ATPase assembly protein, suggesting vacuolar detoxification plays an important role for fungal tolerance to SA. In chemosensitization experiments, co-application of SA with either antimycin A or strobilurin (inhibitors of mitochondrial respiration) resulted in complete growth inhibition of Aspergillus at much lower dose treatment of either agent, alone. Therefore, SA can enhance antifungal activity of commercial antifungal agents required to achieve effective control. SA is a potent antifungal and anti-aflatoxigenic volatile that may have some practical application as a fumigant.
Kim
Jong H
JH
Plant Mycotoxin Research Unit, Western Regional Research Center, USDA-ARS, 800 Buchanan Street, Albany, CA 94710, USA.
Campbell
Bruce C
BC
Mahoney
Noreen
N
Chan
Kathleen L
KL
Molyneux
Russell J
RJ
D000447:Aldehydes / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D000968:Antimycin A / Q000494:pharmacology*; D000975:Antioxidants / Q000378:metabolism; D001230:Aspergillus / Q000187:drug effects* / Q000254:growth & development; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D017353:Gene Deletion; D008689:Methacrylates / Q000494:pharmacology; D009183:Mycotoxins / Q000037:antagonists & inhibitors*; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000378:metabolism; D000073739:Strobilurins
D000447:Aldehydes; D000935:Antifungal Agents; D000975:Antioxidants; D005231:Fatty Acids, Unsaturated; D008689:Methacrylates; D009183:Mycotoxins; D000073739:Strobilurins; C008556:mucidin; C013243:salicylaldehyde; D000968:Antimycin A
Biochem Biophys Res Commun. 2008 Jul 18;372(1):266-71
18486603
Appl Microbiol Biotechnol. 2005 Jun;67(6):807-15
15614562
Phytochem Anal. 2003 Jan-Feb;14(1):8-12
12597250
FEMS Microbiol Lett. 2002 Mar 5;208(2):227-32
11959441
Comp Funct Genomics. 2004;5(3):216-24
18629161
Med Mycol. 1999 Dec;37(6):375-89
10647118
Microbios. 1998;93(374):43-54
9670554
J Biol Chem. 2002 Oct 18;277(42):39187-94
12161436
J Chem Ecol. 2008 Feb;34(2):179-88
18236110
J Bacteriol. 2001 May;183(10):2971-8
11325923
Curr Opin Biotechnol. 2005 Apr;16(2):225-30
15831391
Plant Physiol. 1999 Feb;119(2):627-34
9952459
Microbiol Mol Biol Rev. 2005 Jun;69(2):262-91
15944456
J Infect. 2000 Nov;41(3):203-20
11120607
Nature. 1947 Jun 21;159(4051):850
20343980
J Exp Biol. 1992 Nov;172:19-27
1337091
Pest Manag Sci. 2003 May;59(5):499-511
12741518
Int J Food Microbiol. 2008 Feb 29;122(1-2):49-60
18166238
Clin Microbiol Rev. 1999 Oct;12(4):501-17
10515900
Curr Genet. 2000 May;37(5):277-84
10853763
Nat Prod Rep. 2006 Dec;23(6):851-63
17119635
Med Mycol. 2002 Jun;40(3):259-62
12146755
FEMS Microbiol Lett. 2008 Apr;281(1):64-72
18284447
Genes Cells. 1998 Aug;3(8):485-98
9797451
Mol Microbiol. 2001 Jun;40(5):1067-83
11401713
J Invest Dermatol. 2000 Feb;114(2):354-64
10651998
Biofactors. 2006;27(1-4):109-20
17012768
J Exp Bot. 2001 Oct;52(363):1969-80
11559732
Appl Environ Microbiol. 1994 Aug;60(8):2811-7
16349349
J Antibiot (Tokyo). 1999 May;52(5):480-4
10480572
Food Addit Contam. 2003 May;20(5):490-3
12775468
Science. 1999 Aug 6;285(5429):901-6
10436161
Annu Rev Genet. 2004;38:725-48
15568991